Cure8 research brief
Rising IBD prevalence across Asia means more people will need diagnosis, long-term care, and health-system resources; patterns differ by country and by Crohn's disease versus ulcerative colitis, which affects planning and access to care.
Clinicians and health systems in Asian countries, researchers studying IBD epidemiology, and patients and advocacy groups interested in regional burden and service planning.
This paper pooled GBD 2023 estimates to describe trends in IBD, ulcerative colitis, Crohn's disease, and indeterminate colitis across 34 Asian countries from 1990–2023.
The authors report increasing age-standardized prevalence rates (ASPRs) across all regions and generally decreasing age-standardized disability-adjusted life year rates (ASDRs), though some countries (notably Mauritius and Thailand) show rising ASDRs driven in part by epidemiological changes rather than just population aging or growth.
The study identifies national and regional differences — for example, Bangladesh and Central Asia had high ASDRs in 2023, while South Asia and the Republic of Korea had high prevalence. The authors recommend subtype-specific surveillance, earlier diagnosis, and tailoring long-term care strategies to national patterns and health-system capacity.
This summary is grounded in the article abstract reporting Global Burden of Disease (GBD) 2023 estimates. GBD uses modeling and ICD-10 coding to estimate prevalence and DALYs; country-level estimates can be sensitive to data availability and modeling assumptions.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This paper explores whether polygenic risk scores (PRS) predict key long-term outcomes after IBD diagnosis — notably intestinal surgery — which could be relevant for risk stratification research and future clinical tools...
The study suggests measurable retinal and choroidal microvascular differences in people with IBD versus controls, which could point to systemic vascular effects of inflammation and offer noninvasive biomarker...
This research suggests genetic risk scores could help identify people with IBD who are more likely to have severe disease, which might eventually inform earlier monitoring or treatment decisions. It’s a step toward more...
